Neuroendocrine Response in Pediatric Febrile Seizures
Febrile Seizures in Children: Association of Thyroxine (T4), Epinephrine, and Norepinephrine Levels With Seizure Characteristics and Hospital Outcomes-A Prospective Controlled Observational Study
1 other identifier
observational
120
1 country
1
Brief Summary
Febrile seizures are the most common seizure type in early childhood and usually occur during febrile illnesses. Although most febrile seizures are benign, the biological stress response during seizures is not fully understood. In particular, changes in thyroid hormones and stress-related hormones released by the sympathetic nervous system may play a role in seizure characteristics and clinical outcomes. This prospective observational study aims to evaluate the neuroendocrine response in children presenting with febrile seizures by measuring serum thyroxine (T4), epinephrine, and norepinephrine levels. These measurements will be obtained during the acute phase after seizure cessation and compared with levels measured at recovery and with febrile children without seizures. The study will examine the relationship between neuroendocrine marker levels and seizure characteristics such as seizure duration and recurrence, as well as clinical outcomes including length of hospital stay and need for pediatric intensive care unit admission. By improving understanding of the hormonal stress response associated with febrile seizures, this study aims to contribute to the knowledge of seizure pathophysiology in childhood and may help identify biological factors associated with more severe clinical courses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 2, 2026
CompletedFirst Posted
Study publicly available on registry
March 11, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
March 11, 2026
March 1, 2026
1 year
March 2, 2026
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in acute neuroendocrine hormone levels between febrile seizure patients and febrile controls
The difference in serum thyroxine (T4), epinephrine, and norepinephrine levels measured during the acute phase between children presenting with febrile seizures and age-matched febrile children without seizures.
Baseline (during the emergency department presentation)
Secondary Outcomes (3)
Association between neuroendocrine hormone levels and seizure duration
Baseline (during the index febrile seizure event)
Association between neuroendocrine hormone levels and hospital length of stay
From hospital admission through discharge (up to 7 days)
Association between neuroendocrine hormone levels and pediatric intensive care unit admission
During the index hospitalization (up to 7 days)
Study Arms (2)
Febrile Seizure Patients
Children aged 6 months to 5 years presenting with febrile seizures who are enrolled prospectively. Blood samples are obtained within 30 minutes after seizure cessation to assess acute neuroendocrine response, including thyroxine (T4), epinephrine, and norepinephrine levels. Additional samples are collected prior to hospital discharge. Clinical data including seizure characteristics, recurrence, length of hospital stay, and need for pediatric intensive care unit admission are recorded. No experimental intervention is administered.
Febrile Controls
Age-matched febrile children without seizures enrolled as the control cohort. Blood samples are obtained during the febrile episode to measure thyroxine (T4), epinephrine, and norepinephrine levels. Clinical data related to fever characteristics are collected for comparison with the febrile seizure cohort. No experimental intervention is administered.
Eligibility Criteria
The study population includes children aged 6 months to 5 years presenting with febrile seizures and an age-matched febrile control group without seizures, enrolled prospectively in a pediatric emergency department. The study evaluates differences in acute neuroendocrine hormone levels (thyroxine \[T4\], epinephrine, and norepinephrine) and their associations with seizure characteristics and short-term hospital outcomes.
You may qualify if:
- Children aged 6 months to 5 years presenting to the pediatric emergency department with fever (documented at presentation or reported by caregiver within the preceding 24 hours).
- Case group: febrile seizure occurring in the context of a febrile illness.
- Control group: febrile illness without seizure, selected to be age-matched to cases (e.g., within ±6 months).
- Written informed consent obtained from a parent or legal guardian.
You may not qualify if:
- Suspected or confirmed central nervous system infection (e.g., meningitis, encephalitis).
- Prior diagnosis of epilepsy or history of afebrile seizures.
- Seizures attributable to acute metabolic derangements at presentation (e.g., significant hypoglycemia, clinically relevant electrolyte disturbances).
- Known thyroid disease or use of thyroid hormone/antithyroid medications.
- Known adrenal disorders or use of systemic catecholamine infusions at enrollment.
- Major chronic neurologic disorders or acute head trauma.
- Inability to obtain blood samples within protocol-defined time windows.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aydin Adnan Menderes University Hospital
Aydin, Aydın, 09010, Turkey (Türkiye)
Related Publications (4)
Asami T, Sasagawa F, Kyo S, Asami K, Uchiyama M. Incidence of febrile convulsions in children with congenital hypothyroidism. Acta Paediatr. 1998 Jun;87(6):623-6. doi: 10.1080/080352598750014003.
PMID: 9686652BACKGROUNDThebault-Dagher F, Lafontaine MP, Knoth IS, Deguire F, Sheppard E, Cook R, Lagace M, Gravel J, Lupien S, Lippe S. Febrile seizures and increased stress sensitivity in children: How it relates to seizure characteristics. Epilepsy Behav. 2019 Jun;95:154-160. doi: 10.1016/j.yebeh.2019.03.022. Epub 2019 May 3.
PMID: 31059921BACKGROUNDLadd JM, Sabsabi B, von Oettingen JE. Thyroid Storm in a Toddler Presenting as a Febrile Seizure. Pediatrics. 2020 Feb;145(2):e20191920. doi: 10.1542/peds.2019-1920.
PMID: 31980544BACKGROUNDHan JY, Lee IG, Shin S, Park J. Seizure duration may increase thyroid-stimulating hormone levels in children experiencing a seizure. J Int Med Res. 2020 May;48(5):300060519888401. doi: 10.1177/0300060519888401. Epub 2019 Nov 27.
PMID: 31774013BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 2, 2026
First Posted
March 11, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share